Biliary atresia differential diagnosis

Revision as of 19:55, 10 March 2022 by Saud Khan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Biliary atresia Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Biliary atresia from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Biliary atresia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Biliary atresia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Biliary atresia differential diagnosis

CDC on Biliary atresia differential diagnosis

Biliary atresia differential diagnosis in the news

Blogs on Biliary atresia differential diagnosis

Directions to Hospitals Treating Biliary atresia

Risk calculators and risk factors for Biliary atresia differential diagnosis

Overview

Biliary atresia must be differentiated from other diseases that present with symptoms typical of cholestasis in neonates, jaundice and acholic pale stools, which are main features of obstructive jaundice, associated with conjugated (direct) hyperbilirubinemia.

Differentiating biliary atresia from other Diseases

Biliary atresia must be differentiated from other diseases that cause cholestatic jaundice and hepatic fibrosis, such as:[1]

  • Alagille Syndrome
    • Presents with cholestatic jaundice, along with a variety of other manifestations such as renal, otic, skeletal, ocular and cardiovascular.
  • Byler disease
    • Progressive Familial Intrahepatic cholestasis (PFIC), an inherited mutation in the ATP8b1 gene that results in the cells of the liver not being able to release bile. This leads to cholestasis and jaundice. Careful history taking can help in differentiating this disease from biliary atresia.
  • Congenital biliary dilatation
  • Choledochal Cysts
  • Cholestasis
  • Galactose-1-Phosphate Uridyltransferase Deficiency (Galactosemia)
  • Idiopathic neonatal hepatitis
  • Inborn errors of bile acid synthesis
  • Neonatal Hemochromatosis
  • Intrahepatic bile duct hypoplasia
  • Lipid Storage Disorders
  • Caroli Disease
    • Caroli disease is the dilatation of larger intrahepatic bile ducts, whereas Caroli syndrome is the combination of dilated small bile ducts and congenital hepatic fibrosis. These present in childhood usually, whereas biliary atresia presents in neonates.
  • Cystic Fibrosis
  • Bile plug syndrome
    • This is a rare form of extrahepatic mechanical obstruction in the major bile duct which is caused by viscous bile (sludge) within its lumen. It presents identically to biliary atresia, diagnosis is confirmed on ultrasound which shows sludge in the lumen of the common bile duct.
  • Toxoplasmosis, other infections, rubella, cytomegalovirus infection, and herpes simplex [TORCH][2]


References

  1. Schreiber RA, Harpavat S, Hulscher JBF, Wildhaber BE (2022). "Biliary Atresia in 2021: Epidemiology, Screening and Public Policy". J Clin Med. 11 (4). doi:10.3390/jcm11040999. PMC 8876662 Check |pmc= value (help). PMID 35207269 Check |pmid= value (help).
  2. Mack CL, Sokol RJ (2005). "Unraveling the pathogenesis and etiology of biliary atresia". Pediatr Res. 57 (5 Pt 2): 87R–94R. doi:10.1203/01.PDR.0000159569.57354.47. PMID 15817506.